Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Substrates for sudden cardiac death.

Christopher L Case1

  • 1Arrhythmia Center, Cook Children's Medical Center, 901 Seventh Avenue, Suite 310, Ft. Worth, TX 76104, USA. ccase@cookchildrens.org

Pediatric Clinics of North America
|August 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial.

EClinicalMedicine·2022
Same author

Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.

The Lancet. Infectious diseases·2022
Same author

Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial.

Nature medicine·2022
Same author

Triggering of RNA interference with RNA-RNA, RNA-DNA, and DNA-RNA nanoparticles.

ACS nano·2014
Same author

Co-transcriptional production of RNA-DNA hybrids for simultaneous release of multiple split functionalities.

Nucleic acids research·2013
Same author

Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to Legionella pneumophila.

Proceedings of the National Academy of Sciences of the United States of America·2013
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

Identifying cardiac abnormalities before an event is crucial for preventing sudden cardiac death (SCD) in all age groups. Modifying these cardiac substrates is key to SCD prevention strategies, especially in children.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Pediatric Cardiology

Background:

  • Sudden cardiac death (SCD) is a significant concern in both pediatric and adult populations.
  • Identifying specific cardiac substrate abnormalities is critical for risk stratification.

Purpose of the Study:

  • To emphasize the importance of pre-event identification of cardiac substrate abnormalities.
  • To highlight the role of substrate modification in preventing sudden cardiac death.

Main Methods:

  • Review of existing literature on cardiac substrate abnormalities and SCD.
  • Analysis of risk factors associated with cardiac substrate abnormalities.
  • Discussion of preventive strategies targeting identified substrates.

Main Results:

Related Experiment Videos

  • Certain cardiac substrate abnormalities place individuals at increased risk for SCD.
  • Early identification allows for targeted interventions.
  • Modification of these substrates is a viable prevention strategy.

Conclusions:

  • Pre-event identification of cardiac substrate abnormalities is essential for SCD prevention.
  • Preventive strategies must focus on identifying and modifying at-risk cardiac substrates.
  • This approach is vital for both pediatric and adult populations.